Journal article

A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy

Emily J Lelliott, Carleen Cullinane, Claire A Martin, Rachael Walker, Kelly M Ramsbottom, Fernando Souza-Fonseca-Guimaraes, Shatha Abuhammad, Jessica Michie, Laura Kirby, Richard J Young, Alison Slater, Peter Lau, Katrina Meeth, Jane Oliaro, Nicole Haynes, Grant A McArthur, Karen E Sheppard

Scientific Reports | NATURE PUBLISHING GROUP | Published : 2019

Grants

Awarded by NHMRC of Australia


Awarded by Melbourne Research Scholarship (University of Melbourne)


Awarded by NHMRC Early Career Fellowship


Awarded by National Breast Cancer Foundation (NBCF) Fellowship


Awarded by NHMRC New Investigator Grant


Awarded by Priority-driven Collaborative Cancer Research Scheme


Funding Acknowledgements

This work was supported by grants from the NHMRC of Australia to GAM, KES, CC & NH (#1100189) and from Pfizer Oncology. EL was supported by a Peter MacCallum Cancer Centre Postgraduate Scholarship, Melbourne Research Scholarship (University of Melbourne; 58616) and a Cancer Therapeutics CRC (CTx) PhD Top Up Scholarship. FSFG was supported by a NHMRC Early Career Fellowship (1088703), a National Breast Cancer Foundation (NBCF) Fellowship (PF-15-008), a NHMRC New Investigator Grant (1140406), and a grant (1120725) awarded through the Priority-driven Collaborative Cancer Research Scheme and funded by Cure Cancer Australia with the assistance of Cancer Australia.